These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32881673)

  • 1. Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema.
    Nissen TPH; Vorum H; Aasbjerg K
    Curr Drug Saf; 2021; 16(1):17-31. PubMed ID: 32881673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on current pharmacologic therapies for diabetic retinopathy.
    Muns SM; Villegas VM; Flynn HW; Schwartz SG
    Expert Opin Pharmacother; 2023; 24(14):1577-1593. PubMed ID: 37431888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).
    Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I
    Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights in Resistant Diabetic Macular Edema.
    Kuroiwa DAK; Malerbi FK; Regatieri CVS
    Ophthalmologica; 2021; 244(6):485-494. PubMed ID: 34023834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-VEGF therapy for diabetic retinopathy].
    Chekhonin ES; Fayzrakhmanov RR; Sukhanova AV; Bosov ED
    Vestn Oftalmol; 2021; 137(4):136-142. PubMed ID: 34410069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections.
    Cetin EN; Demirtaş Ö; Özbakış NC; Pekel G
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1801-1806. PubMed ID: 29922890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic Macular Edema].
    Barth T; Helbig H
    Klin Monbl Augenheilkd; 2021 Sep; 238(9):1029-1043. PubMed ID: 34380156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive cerebral hemorrhage with undetectable plasma vascular endothelial growth factor levels in a patient receiving intravitreal injection of aflibercept for bilateral diabetic macular edema: a case report.
    Yoshimoto M; Takeda N; Yoshimoto T; Matsumoto S
    J Med Case Rep; 2021 Jul; 15(1):403. PubMed ID: 34311786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Holekamp NM; Campbell J; Almony A; Ingraham H; Marks S; Chandwani H; Cole AL; Kiss S
    Am J Ophthalmol; 2018 Jul; 191():83-91. PubMed ID: 29684329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
    Antoszyk AN; Tarnowski KW; Basu K; Ehrlich JS; Haskova Z
    Ophthalmol Retina; 2020 Oct; 4(10):1034-1036. PubMed ID: 32512056
    [No Abstract]   [Full Text] [Related]  

  • 12. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch.
    Ruiz-Medrano J; Rodríguez-Leor R; Almazán E; Lugo F; Casado-Lopez E; Arias L; Ruiz-Moreno JM
    Eur J Ophthalmol; 2021 May; 31(3):1135-1145. PubMed ID: 32493065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema.
    Elnahry AG; Abdel-Kader AA; Habib AE; Elnahry GA; Raafat KA; Elrakhawy K
    Rev Recent Clin Trials; 2020; 15(3):188-198. PubMed ID: 32427087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes.
    Lukic M; Williams G; Shalchi Z; Patel PJ; Hykin PG; Hamilton RD; Rajendram R
    Eur J Ophthalmol; 2021 May; 31(3):1201-1207. PubMed ID: 32429690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.
    Ross EL; Hutton DW; Stein JD; Bressler NM; Jampol LM; Glassman AR;
    JAMA Ophthalmol; 2016 Aug; 134(8):888-96. PubMed ID: 27280850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight-Week Outcomes.
    Bahrami B; Hong T; Schlub TE; Chang AA
    Retina; 2019 Jan; 39(1):61-68. PubMed ID: 30015767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
    Agarwal A; Sarwar S; Sepah YJ; Nguyen QD
    Curr Opin Ophthalmol; 2015 May; 26(3):177-83. PubMed ID: 25784111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in management of diabetic macular edema.
    Tripathy K; Sharma YR; R K; Chawla R; Gogia V; Singh SK; Venkatesh P; Vohra R
    Curr Diabetes Rev; 2015; 11(2):79-97. PubMed ID: 25801496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.